Etiologia schizofrenii (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Etiologia schizofrenii" in Polish language version.

refsWebsite
Global rank Polish rank
4th place
7th place
5th place
2nd place
2nd place
6th place
4,032nd place
2,809th place
1st place
1st place
low place
low place
744th place
657th place
719th place
1,030th place

ash.org.uk

doi.org

dx.doi.org

medscape.com

nationalarchives.gov.uk

webarchive.nationalarchives.gov.uk

  • Meltzer H i inni, OPCS Surveys of Psychiatric Morbidity Report 3: Economic Activity and Social Functioning of Adults With Psychiatric Disorders., London, Her Majesty’s Stationery Office, 1995. Available for fee.

nih.gov

ncbi.nlm.nih.gov

psychiatryonline.org

ajp.psychiatryonline.org

web.archive.org

worldcat.org

  • Andreas Meyer-Lindenberg i inni, Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia, „Nature Neuroscience”, 5 (3), 2002, s. 267–271, DOI10.1038/nn804, ISSN 1097-6256, PMID11865311.
  • Paul J. Harrison, Michael J. Owen, Genes for schizophrenia? Recent findings and their pathophysiological implications, „The Lancet”, 361 (9355), 2003, s. 417–419, DOI10.1016/S0140-6736(03)12379-3, ISSN 0140-6736, PMID12573388.
  • R. Day i inni, Stressful life events preceding the acute onset of schizophrenia: a cross-national study from the World Health Organization, „Culture, Medicine and Psychiatry”, 11 (2), 1987, s. 123–205, ISSN 0165-005X, PMID3595169.
  • Cheryl Corcoran i inni, The stress cascade and schizophrenia: etiology and onset, „Schizophrenia Bulletin”, 29 (4), 2003, s. 671–692, ISSN 0586-7614, PMID14989406.
  • Regina A. Shih, Pamela L. Belmonte, Peter P. Zandi, A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders, „International Review of Psychiatry (Abingdon, England)”, 16 (4), 2004, s. 260–283, DOI10.1080/09540260400014401, ISSN 0954-0261, PMID16194760.
  • M.J. Owen, N. Craddock, M.C. O'Donovan, Schizophrenia: genes at last?, „Trends in genetics: TIG”, 21 (9), 2005, s. 518–525, DOI10.1016/j.tig.2005.06.011, ISSN 0168-9525, PMID16009449.
  • Michael C. O'Donovan, Nigel M. Williams, Michael J. Owen, Recent advances in the genetics of schizophrenia, „Human Molecular Genetics”, 12 Spec No 2, 2003, R125–133, DOI10.1093/hmg/ddg302, ISSN 0964-6906, PMID12952866.
  • Nick Craddock, Michael C. O'Donovan, Michael J. Owen, Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology, „Schizophrenia Bulletin”, 32 (1), 2006, s. 9–16, DOI10.1093/schbul/sbj033, ISSN 0586-7614, PMID16319375, PMCIDPMC2632175.
  • J.T. Dalby, D. Morgan, M.L. Lee, Schizophrenia and mania in identical twin brothers, „The Journal of Nervous and Mental Disease”, 174 (5), 1986, s. 304–308, ISSN 0022-3018, PMID3701318.
  • Alan S. Brown, Prenatal infection as a risk factor for schizophrenia, „Schizophrenia Bulletin”, 32 (2), 2006, s. 200–202, DOI10.1093/schbul/sbj052, ISSN 0586-7614, PMID16469941, PMCIDPMC2632220.
  • Jim van Os i inni, The schizophrenia envirome, „Current Opinion in Psychiatry”, 18 (2), 2005, s. 141–145, ISSN 0951-7367, PMID16639166.
  • Kim T. Mueser, Susan R. McGurk, Schizophrenia, „The Lancet”, 363 (9426), London, England 2004, s. 2063–2072, DOI10.1016/S0140-6736(04)16458-1, ISSN 1474-547X, PMID15207959.
  • Jean-Paul Selten, Elizabeth Cantor-Graae, René S. Kahn, Migration and schizophrenia, „Current Opinion in Psychiatry”, 20 (2), 2007, s. 111–115, DOI10.1097/YCO.0b013e328017f68e, ISSN 0951-7367, PMID17278906.
  • Lindsay S. Schenkel i inni, Histories of childhood maltreatment in schizophrenia: relationships with premorbid functioning, symptomatology, and cognitive deficits, „Schizophrenia Research”, 76 (2-3), 2005, s. 273–286, DOI10.1016/j.schres.2005.03.003, ISSN 0920-9964, PMID15949659.
  • I. Janssen i inni, Childhood abuse as a risk factor for psychotic experiences, „Acta Psychiatrica Scandinavica”, 109 (1), 2004, s. 38–45, ISSN 0001-690X, PMID14674957.
  • Richard P. Bentall i inni, Prospects for a cognitive-developmental account of psychotic experiences, „The British Journal of Clinical Psychology”, 46 (Pt 2), 2007, s. 155–173, DOI10.1348/014466506X123011, ISSN 0144-6657, PMID17524210.
  • Kenneth L. Subotnik i inni, Are communication deviance and expressed emotion related to family history of psychiatric disorders in schizophrenia?, „Schizophrenia Bulletin”, 28 (4), 2002, s. 719–729, ISSN 0586-7614, PMID12795501.
  • E. Fuller Torrey, Robert H. Yolken, Toxoplasma gondii and schizophrenia, „Emerging Infectious Diseases”, 9 (11), 2003, s. 1375–1380, DOI10.3201/eid0911.030143, ISSN 1080-6040, PMID14725265, PMCIDPMC3035534.
  • H.-L. Wang i inni, Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia, „Acta Psychiatrica Scandinavica”, 114 (1), 2006, s. 40–48, DOI10.1111/j.1600-0447.2006.00780.x, ISSN 0001-690X, PMID16774660.
  • Lynsey Gregg, Christine Barrowclough, Gillian Haddock, Reasons for increased substance use in psychosis, „Clinical Psychology Review”, 27 (4), 2007, s. 494–510, DOI10.1016/j.cpr.2006.09.004, ISSN 0272-7358, PMID17240501.
  • Marc Laruelle i inni, Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects, „Proceedings of the National Academy of Sciences of the United States of America”, 93 (17), 1996, s. 9235–9240, ISSN 0027-8424, PMID8799184, PMCIDPMC38625.
  • K.T. Mueser i inni, Prevalence of substance abuse in schizophrenia: demographic and clinical correlates, „Schizophrenia Bulletin”, 16 (1), 1990, s. 31–56, ISSN 0586-7614, PMID2333480.
  • Louise Arseneault i inni, Causal association between cannabis and psychosis: examination of the evidence, „The British Journal of Psychiatry: The Journal of Mental Science”, 184, 2004, s. 110–117, DOI10.1192/bjp.184.2.110, ISSN 0007-1250, PMID14754822.
  • S. Andréasson i inni, Cannabis and schizophrenia. A longitudinal study of Swedish conscripts, „The Lancet”, 2 (8574), London, England 1987, s. 1483–1486, ISSN 0140-6736, PMID2892048.
  • Stanley Zammit i inni, Investigating the association between cigarette smoking and schizophrenia in a cohort study, „The American Journal of Psychiatry”, 160 (12), 2003, s. 2216–2221, DOI10.1176/appi.ajp.160.12.2216, ISSN 0002-953X, PMID14638593.
  • Matthew R. Broome i inni, What causes the onset of psychosis?, „Schizophrenia Research”, 79 (1), 2005, s. 23–34, DOI10.1016/j.schres.2005.02.007, ISSN 0920-9964, PMID16198238.
  • Ralph Lewis, Should cognitive deficit be a diagnostic criterion for schizophrenia?, „Journal of psychiatry & neuroscience: JPN”, 29 (2), 2004, s. 102–113, ISSN 1180-4882, PMID15069464.
  • Martin Brüne i inni, Mental state attribution, neurocognitive functioning, and psychopathology: what predicts poor social competence in schizophrenia best?, „Schizophrenia Research”, 92 (1-3), 2007, s. 151–159, DOI10.1016/j.schres.2007.01.006, ISSN 0920-9964, PMID17346931.
  • Margriet M. Sitskoorn i inni, Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis, „Schizophrenia Research”, 71 (2-3), 2004, s. 285–295, DOI10.1016/j.schres.2004.03.007, ISSN 0920-9964, PMID15474899.
  • Matthew M. Kurtz, Neurocognitive impairment across the lifespan in schizophrenia: an update, „Schizophrenia Research”, 74 (1), 2005, s. 15–26, DOI10.1016/j.schres.2004.07.005, ISSN 0920-9964, PMID15694750.
  • Alex S. Cohen, Nancy M. Docherty, Affective reactivity of speech and emotional experience in patients with schizophrenia, „Schizophrenia Research”, 69 (1), 2004, s. 7–14, DOI10.1016/S0920-9964(03)00069-0, ISSN 0920-9964, PMID15145465.
  • William P. Horan, Jack J. Blanchard, Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping, „Schizophrenia Research”, 60 (2-3), 2003, s. 271–283, ISSN 0920-9964, PMID12591589.
  • Christine Barrowclough i inni, Self-esteem in schizophrenia: relationships between self-evaluation, family attitudes, and symptomatology, „Journal of Abnormal Psychology”, 112 (1), 2003, s. 92–99, DOI10.1037/0021-843X.112.1.92, ISSN 0021-843X, PMID12653417.
  • M. Birchwood i inni, The power and omnipotence of voices: subordination and entrapment by voices and significant others, „Psychological Medicine”, 30 (2), 2000, s. 337–344, ISSN 0033-2917, PMID10824654.
  • Ben Smith i inni, Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations, „Schizophrenia Research”, 86 (1-3), 2006, s. 181–188, DOI10.1016/j.schres.2006.06.018, ISSN 0920-9964, PMID16857346.
  • Vaughan Bell, Peter W. Halligan, Hadyn D. Ellis, Explaining delusions: a cognitive perspective, „Trends in Cognitive Sciences”, 10 (5), 2006, s. 219–226, DOI10.1016/j.tics.2006.03.004, ISSN 1364-6613, PMID16600666.
  • Elizabeth Kuipers i inni, Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms, „Schizophrenia Bulletin”, 32 Suppl 1, 2006, S24–31, DOI10.1093/schbul/sbl014, ISSN 0586-7614, PMID16885206, PMCIDPMC2632539.
  • Michael F. Green, Cognitive impairment and functional outcome in schizophrenia and bipolar disorder, „The Journal of Clinical Psychiatry”, 67 Suppl 9, 2006, 3–8; discussion 36–42, ISSN 0160-6689, PMID16965182.
  • H.M. Jones, L.S. Pilowsky, Dopamine and antipsychotic drug action revisited, „The British Journal of Psychiatry: The Journal of Mental Science”, 181, 2002, s. 271–275, ISSN 0007-1250, PMID12356650.
  • Christine Konradi, Stephan Heckers, Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment, „Pharmacology & Therapeutics”, 97 (2), 2003, s. 153–179, ISSN 0163-7258, PMID12559388, PMCIDPMC4203361.
  • A.C. Lahti i inni, Effects of ketamine in normal and schizophrenic volunteers, „Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology”, 25 (4), 2001, s. 455–467, DOI10.1016/S0893-133X(01)00243-3, ISSN 0893-133X, PMID11557159.
  • Joseph T. Coyle, Guochuan Tsai, Donald Goff, Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia, „Annals of the New York Academy of Sciences”, 1003, 2003, s. 318–327, ISSN 0077-8923, PMID14684455.
  • Harri J. Tuominen, Jari Tiihonen, Kristian Wahlbeck, Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis, „Schizophrenia Research”, 72 (2-3), 2005, s. 225–234, DOI10.1016/j.schres.2004.05.005, ISSN 0920-9964, PMID15560967.
  • E.C. Johnstone i inni, Cerebral ventricular size and cognitive impairment in chronic schizophrenia, „The Lancet”, 2 (7992), London, England 1976, s. 924–926, ISSN 0140-6736, PMID62160.
  • Laura A. Flashman, Michael F. Green, Review of cognition and brain structure in schizophrenia: profiles, longitudinal course, and effects of treatment, „The Psychiatric Clinics of North America”, 27 (1), 2004, s. 1–18, vii, DOI10.1016/S0193-953X(03)00105-9, ISSN 0193-953X, PMID15062627.
  • Kazuo Yamada i inni, Effectiveness of nilvadipine in two cases of chronic schizophrenia, „Psychiatry and Clinical Neurosciences”, 49 (4), 1995, s. 237–238, DOI10.1111/j.1440-1819.1995.tb01891.x, ISSN 1323-1316, PMID9179944.
  • William W. Eaton i inni, Association of schizophrenia and autoimmune diseases: linkage of Danish national registers, „The American Journal of Psychiatry”, 163 (3), 2006, s. 521–528, DOI10.1176/appi.ajp.163.3.521, ISSN 0002-953X, PMID16513876.
  • Amanda L. Jones i inni, Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?, „Immunology and Cell Biology”, 83 (1), 2005, s. 9–17, DOI10.1111/j.1440-1711.2005.01305.x, ISSN 0818-9641, PMID15661036.
  • Rael D. Strous, Yehuda Shoenfeld, Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited, „Journal of Autoimmunity”, 27 (2), 2006, s. 71–80, DOI10.1016/j.jaut.2006.07.006, ISSN 0896-8411, PMID16997531.